In Vitro Efficacy and Pharmacodynamic Indices for Antibiotics against Coagulase-Negative Staphylococcus Endophthalmitis Isolates

Ophthalmology

Volumn 114, Issue 5, 2007, Pages 871-875

  Harper, Tom ^a   Miller, Darlene ^a   Flynn Jr , Harry W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; GATIFLOXACIN; LINEZOLID; MOXIFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; AQUEOUS HUMOR; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOPHTHALMITIS; EXPERIMENTAL STUDY; HUMAN; HUMAN TISSUE; MAXIMUM PLASMA CONCENTRATION; MCNEMAR TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ACETAMIDES; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; AZA COMPOUNDS; BIOLOGICAL AVAILABILITY; COAGULASE; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; OXAZOLIDINONES; QUINOLINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; VANCOMYCIN; VIRGINIAMYCIN;

EID: 34247363511     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.01.007     Document Type: Article

References (27)

1. Aaberg Jr. T.M., Flynn Jr. H.W., Schiffman J., and Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology 105 (1998) 1004-1010
2. Eifrig C.W., Flynn Jr. H.W., Scott I.U., and Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers 33 (2002) 373-378
3. Miller J.J., Scott I.U., Flynn Jr. H.W., et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139 (2005) 983-987
4. Buzard K., and Liapis S. Prevention of endophthalmitis. J Cataract Refract Surg 30 (2004) 1953-1959
5. Benz M.S., Scott I.U., Flynn Jr. H.W., et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 137 (2004) 38-42
6. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109 (2002) 13-24
7. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
8. Hwang D.G. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 suppl (2004) S79-S83
9. Mah F.S. Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 15 (2004) 316-320
10. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136 (2003) 500-505
11. MS100-S16. Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement (2006), National Committee for Clinical Laboratory Standards, Wayne, NJ 118-122
12. Alster Y., Herlin L., Lazar M., and Loewenstein A. Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids. Br J Ophthalmol 84 (2000) 300-302
13. Solomon R., Donnenfeld E.D., Perry H.D., et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 112 (2005) 466-469
14. Kim D.H., Stark W.J., O'Brien T.P., and Dick J.D. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 112 (2005) 1992-1996
15. McCulley J.P., Caudle D., Aronowicz J.D., and Shine W.E. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 113 (2006) 955-959
16. Hariprasad S.M., Mieler W.F., and Holtz E.R. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 121 (2003) 345-350
17. Hariprasad S.M., Shah G.K., Mieler W.F., et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 124 (2006) 178-182
18. Huerva V., Sinues B., del Buey M.A., et al. Levels of vancomycin in aqueous humor after topical eye drops administration. J Ocul Pharmacol 9 (1993) 167-170
19. Fiscella R.G., Lai W.W., Buerk B., et al. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration. Ophthalmology 111 (2004) 1191-1195
20. Spanu T., Santangelo R., Andreotti F., et al. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome. Int J Antimicrob Agents 23 (2004) 120-128
21. Blondeau J.M., Zhao X., Hansen G., and Drlica K. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 45 (2001) 433-438
22. Wilhelmus K.R. Evaluation and prediction of fluoroquinolone pharmacodynamics in bacterial keratitis. J Ocul Pharmacol Ther 19 (2003) 493-499
23. Chalita M.R., Höfling-Lima A.L., Paranhos Jr. A., et al. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 137 (2004) 43-51
24. Kunimoto D.Y., Das T., Sharma S., et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Am J Ophthalmol 128 (1999) 240-242
25. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466
26. Morrissey I., Burnett R., Viljoen L., and Robbins M. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J Infect 49 (2004) 109-114
27. Recchia F.M., Busbee B.G., Pearlman R.B., et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 123 (2005) 341-346